Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington, shared a post on X:
“Excellent talk by Bernadett Szabados on peri-op treatment in MIBC synthesizing data from NIAGARA and EV303 trials!
Neoadjuvant systemic therapy is critical to control systemic micrometastasis!”
More posts about MIBC.
